Liz Rendall
Scientific Support Coordinator
Liz is an experienced research scientist who was a member of the P2Y12 antagonist project team at AstraZeneca that lead to the discovery of Brilinta (ticagrelor) and Kengreal (cangrelor).
Subsequently, she worked across a range of projects in BioScience, combining target identification and validation activities with disease knowledge within the respiratory and inflammation research area.
At XenoGesis she combined data/documentation quality control with drug discovery expertise and supported Business Development.
Liz has joined Platelet Services in 2023 to enhance the data management services.
![Liz Rendall](https://plateletservices.com/wp-content/uploads/2023/12/Liz_crop.png)